Family Sues Kratom Manufacturer and Retailer Over Menifee, California Woman's Death
The family of a Menifee, California woman has filed a lawsuit against the manufacturer and retailer of a kratom product they blame for her death, alleging the product was sold with undisclosed opioid-like risks and without adequate warnings, according to ABC7. The family is represented by attorney Michael Jeandron. The reporting does not specify whether the product was a concentrated or synthetic 7-hydroxymitragynine preparation or a natural leaf kratom product, a distinction at the center of current federal and state regulatory action.
The family of a Menifee, California woman has filed a lawsuit against the manufacturer and the retailer of a kratom product they blame for her death, according to ABC7. The reporting does not specify whether the product involved was a concentrated or synthetic 7-hydroxymitragynine (7-OH) preparation or a natural leaf kratom product. That distinction matters for the case's regulatory context: concentrated and synthetic 7-OH products, which contain the alkaloid at levels far above the trace amounts in raw leaf, are the focus of current federal scheduling activity, while botanical kratom remains federally legal.
The suit's allegations center on marketing and warnings. According to ABC7, the complaint asserts that the product was marketed and sold as kratom while posing undisclosed opioid-like risks attributable to the plant's active alkaloids, including mitragynine and 7-OH, and that the defendants failed to warn consumers about the risk of serious adverse events and death despite mounting reports and regulatory scrutiny of kratom-related harms. The family is represented by attorney Michael Jeandron, who ABC7 reports has handled other consumer-product injury cases. The station's reporting does not identify the named defendants or the court where the suit was filed, and does not include a response from the manufacturer or retailer.
The filing joins a growing body of litigation and official action invoking kratom-associated deaths. The Drug Enforcement Administration temporarily placed three synthetic kratom-derived compounds in Schedule I on August 26, citing public safety risk, and state officials have begun citing mortality data in support of broader restrictions, including Iowa's governor, who called for a total statewide kratom ban this week while officials cited 45 deaths in the state since 2024. The complaint's failure-to-warn allegations reference that mounting regulatory scrutiny, according to ABC7's account of the filing.
Sources
-
Family files lawsuit after Southern California woman's death linked to kratom
ABC7
The family of a Menifee woman filed suit against the manufacturer and retailer of a kratom product they blame for her death, alleging the product was marketed as kratom while posing undisclosed opioid-like risks and that the defendants failed to warn of serious adverse events.